SCHEMBL9890442

SCHEMBL9890442

c1ccc2c(c1)c1ccncc1n2-c1ccc2oc3c(ccc4oc5ccc(-n6c7ccccc7c7ccncc76)cc5c43)c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CDK4 P11802 1/20 0.32
CDK6 Q00534 1/20 0.32
JAK2 O60674 1/20 0.32
ZAP70 P43403 1/20 0.32
SYK P43405 1/20 0.32
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.32
IDO1 P14902 1/20 0.32
ALDH1A1 P00352 2/20 0.31
MEN1 O00255 1/20 0.31
POLB P06746 1/20 0.31
TSHR P16473 1/20 0.31
BRCA1 P38398 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD17B10 Q99714 1/20 0.31
MAOA P21397 4/20 0.31
MAOB P27338 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9890453 0.94 CDK4 (0.31) CDK4CDK6
SCHEMBL9890443 0.93 MAOA (0.39) KDM4EATML3MBTL1JAK2ZAP70
SCHEMBL9890188 0.93 KDM4E (0.36) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL13529148 0.93 CDK4 (0.31) KDM4ECDK4CDK6NPC1MAPT
SCHEMBL9890454 0.92 CDK4 (0.31) CDK4CDK6
SCHEMBL13529149 0.92 CDK4 (0.31) CDK4CDK6
SCHEMBL9890574 0.90 KDM4E (0.38) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL16639227 0.90 KDM4E (0.40) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL9890384 0.89 KDM4E (0.41) KDM4EATML3MBTL1NPC1MAPT
SCHEMBL23438635 0.88 KDM4E (0.40) KDM4EATML3MBTL1CDK4CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 KDM4E 990/4885ATM 3103/4885L3MBTL1 709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.